Thrombotic thrombocytopenic purpura (TTP): Initial treatment with plasma exchange plus steroids and immunosuppressive agents for relapsing cases

Renal Failure

Volumn 25, Issue 1, 2003, Pages 21-30

  Yang, Chung Wei ^a   Chen, Yung Chang ^b   Dunn, Po ^b   Chang, Ming Yang ^b   Fang, Ji Tseng ^b   Huang, Chiu Ching ^b  

^a Hsinchu Hospital   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Complete remission; Partial remission; Plasma exchange; Relapse; Thrombotic thrombocytopenic purpura

Indexed keywords

ANTINUCLEAR ANTIBODY; CREATININE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; STEROID; TICLOPIDINE; VINCRISTINE;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DISEASE COURSE; DRUG INDUCED DISEASE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; MALE; MORTALITY; PLASMAPHERESIS; PNEUMONIA; PRIORITY JOURNAL; RELAPSE; STEROID THERAPY; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, HEMOLYTIC; BILIRUBIN; BIOLOGICAL MARKERS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PLASMA EXCHANGE; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RECURRENCE; RETICULOCYTE COUNT; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STEROIDS; SURVIVAL ANALYSIS; TAIWAN; TICLOPIDINE; TREATMENT OUTCOME;

EID: 0037286428     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120017440     Document Type: Article

References (32)

1. Ridolfi, R.L.; Bell, W.R. Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature. Medicine (Baltimore) 1981, 60, 413-428.
2. Moake, J.L.; Rudy, C.K.; Troll, J.H.; Weinstein, M.J.; Colannino, N.M.; Azocar, J.; Seder, R.H.; Hong, S.L.; Deykin, D. Unusually large plasma factor VIII: von Willebrand factor multimeres in chronic relapsing thrombotic thrombocytopenic purpura. N. Engl. J. Med. 1982, 307, 1432-1436.
3. Thompson, C.E.; Damon, L.E.; Ries, C.A.; Linker, C.A. Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood 1992, 80, 1890-1895.
4. Ashkenazi, S. Role of bacterial cytotoxins in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Annu. Rev. Med. 1993, 44, 11-18.
5. Gordon, L.I.; Kwaan, H.C. Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient. Semin. Thromb. Hemost. 1999, 25, 217-221.
6. Egerman, R.S.; Witlin, A.G.; Friedman, S.A.; Sibai, B.M. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in pregnancy: review of 11 cases. Am. J. Obstet. Gynecol. 1996, 175, 950-956.
7. Schriber, J.R.; Herzig, G.P. Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Semin. Hematol. 1997, 34, 126-133.
8. Page, Y.; Tardy, B.; Zeni, F.; Comtet, C.; Terrana, R.; Bertrand, J.C. Thrombotic thrombocytopenic purpura related to ticlopidine. Lancet 1991, 337, 774-776.
9. Bennett, C.L.; Connors, J.M.; Carwile, J.M.; Moake, J.L.; Bell, W.R.; Tarantolo, S.R.; McCarthy, L.J.; Sarode, R.; Hatfield, A.J.; Feldman, M.D.; Davidson, C.J.; Tsai, H.M. Thrombotic thrombocytopenic purpura associated with clopidogrel. New Engl. J. Med. 2000, 342, 1773-1777.
10. Durand, J.M.; Lefevre, P. Mitomycin-induced thrombotic thrombocytopenic purpura: possible successful treatment with vincristine and cyclophosphamide. Hematologica 1991, 76, 421-423.
11. Dzik, W.H.; Georgi, B.A.; Khettry, U.; Jenkins, R.L. Cyclosporine-associated thrombotic thrombocytopenic purpura following liver transplantation-successful treatment with plasma exchange. Transplantation 1987, 44, 570-572.
12. Holman, M.J.; Gonwa, T.A.; Cooper, B.; Husberg, B.S.; Goldstein, R.M.; Gibbs, J.F.; Klintmalm, G.B. FK506-associated thrombotic thrombocytopenic purpura. Transplantation 1993, 55, 205-206.
13. Lacotte, L.; Thierry, A.; Delwail, V.; Dreyfus, B.; Guilhot, F. Thrombotic thrombocytopenic purpura during interferon alpha treatment for chronic myelogenous leukemia. Acta Haematol. 2000, 102, 160-162.
14. Cookson, S.; Krueger, M.L.; Bennett, R.M. Fulminant thrombotic thrombocytopenic purpura in a patient with the limited form of scleroderma: successful outcome using plasma exchange. J. Rheumatol. 1991, 18, 900-901.
15. Gelfand, J.; Truong, L.; Stern, L.; Pirani, C.L.; Appel, G.B. Thrombotic thrombocytopenic purpura syndrome in systemic lupus erythematosus: treatment with plasma infusion. Am. J. Kidney Dis. 1985, 6, 154-160.
16. Rock, G.A.; Shumak, K.H.; Buskard, N.A.; Blanchette, V.S.; Kelton, J.G.; Nair, R.C.; Spasoff, R.A. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian apheresis study group. New Engl. J. Med. 1991, 325, 393-397.
17. de la Rubia, J.; Lopez, A.; Arriaga, F.; Cid, A.R.; Vicente, A.I.; Marty, M.L.; Sanz, M.A. Response to plasma exchange and steroids as combined therapy for patients with thrombotic thrombocytopenic purpura. Acta. Haematol. 1999, 102, 12-16.
18. Bobbio-Pallavicini, E.; Gugliotta, L.; Centurioni, R.; Porta, C.; Vianelli, N.; Billio, A.; Tacconi, F.; Ascari, E. Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian cooperative group for TTP. Hematologica 1997, 82, 429-435.
19. Finazzi, G.; Bellavita, P.; Falanga, A.; Viero, P.; Barbui, T. Inefficacy of intravenous immunoglobulin in patients with low-risk thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome. Am. J. Hematol. 1992, 41, 165-169.
20. Kondo, H.; Imamura, T. Effects of intravenous immunoglobulin in a patient with intermittent thrombotic thrombocytopenic purpura. Br. J. Haematol. 2000, 108, 880-882.
21. Onundarson, P.T.; Rowe, J.M.; Heal, J.M.; Francis, C.W. Response to plasma exchange and splenectomy in thrombotic thrombocytopenic purpura. A 10-year experience at a single institution. Arch. Intern. Med. 1992, 152, 791-796.
22. Veltman, G.A.; Brand, A.; Leeksma, O.C.; ten Bosch, G.J.; van Krieken, J.H.; Briet, E. The role of splenectomy in the treatment of relapsing thrombotic thrombocytopenic purpura. Ann. Hematol. 1995, 70, 231-236.
23. Ferrara, F.; Copia, C.; Annunziata, M.; Spasiano, A.; Di Grazia, C.; Palmieri, S.; Prossomariti, L.; Mele, G. Vincristine as salvage treatment for refractory thrombotic thrombocytopenic purpura. Ann. Hematol. 1999, 78, 521-523.
24. Mazzel, C.; Pepkowitz, S.; Klapper, E.; Goldfinger, D. Treatment of thrombotic thrombocytopenic purpura: a role for early vincristine administration. J. Clin. Apheresis 1998, 13, 20-22.
25. Perez-Sanchez, I.; Anguita, J.; Pintado, T. Use of cyclophosphamide in the treatment of thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus: report of two cases. Ann. Hematol. 1999, 78, 285-287.
26. Hand, J.P.; Lawlor, E.R.; Yong, C.K.; Davis, J.H. Successful use of cyclosporine A in the treatment of refractory thrombotic thrombocytopenic purpura. Br. J. Haematol. 1998, 100, 597-599.
27. Pasquale, D.; Vidhya, R.; DaSilva, K.; Tsan, M.F.; Lansing, L.; Chikkappa, G. Chronic relapsing thrombotic thrombocytopenic purpura: role of therapy with cyclosporine. Am. J. Hematol. 1998, 57, 57-61.
28. Dervenoulas, J.; Tsirigotis, P.; Bollas, G.; Pappa, V.; Xiros, N.; Economopoulos, T.; Pappa, M.; Mellou, S.; Kostourou, A.; Papageorgiou, E.; Raptis, S.A. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 patients. Ann. Hematol. 2000, 79, 66-72.
29. Hollenbeck, M.; Kutkuhn, B.; Aul, C.; Leschke, M.; Willers, R.; Grabensee, B. Haemolytic-uraemic syndrome and thrombotic-thrombocytopenic purpura in adults: clinical findings and prognostic factors for death and end-stage renal disease. Nephrol. Dial. Transplant 1998, 13, 76-81.
30. Furlan, M.; Robles, R.; Solenthaler, M.; Lammle, B. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood 1998, 91, 2839-2846.
31. Furlan, M.; Robles, R.; Galbusera, M.; Remuzzi, G.; Kyrle, P.A.; Brenner, B.; Krause, M.; Scharrer, I.; Aumann, V.; Mittler, U.; Solenthaler, M.; Lammle, B. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. N. Engl. J. Med. 1998, 339, 1578-1584.
32. Tsai, H.M.; Lian, E.C. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N. Engl. J. Med. 1998, 339, 1585-1594.